Correction: IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma (Oncogene, (2022), 41, 4, (600-611), 10.1038/s41388-021-02111-x)

Dawei Song; Sonia Cismas; Caitrin Crudden; Eric Trocme; Claire Worrall; Naida Suleymanova; Tingting Lin; Huiyuan Zheng; Stefan Seregard; Ada Girnita; Leonard Girnita

doi:https://doi.org/10.1038/s41388-023-02607-8

Correction: IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma (Oncogene, (2022), 41, 4, (600-611), 10.1038/s41388-021-02111-x)

Dawei Song, Sonia Cismas, Caitrin Crudden, Eric Trocme, Claire Worrall, Naida Suleymanova, Tingting Lin, Huiyuan Zheng, Stefan Seregard, Ada Girnita, Leonard Girnita

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Abstract

Following the publication of this article, the authors noted errors in the assembly of Fig. 2b. A corrected version is provided in which the western blot panel for the cell line CM2 has been replaced with images from an alternative repeat for the pIGF1R/IGF1R and pAkt/Akt. In addition, the CM1 panel is updated with longer exposure images for pIGF1R/IGF1R and pAkt to better demonstrate the absence of IGF1R and IGF1-induced signaling activation in this cell line. The description of the results and the figure legend remain unchanged, and the authors confirm that conclusions of this article are not affected by this correction. The authors apologize for any inconvenience this may have caused for readers.

Original language	English
Pages (from-to)	858
Number of pages	1
Journal	Oncogene
Volume	42
Issue number	11
Early online date	2023
DOIs	https://doi.org/10.1038/s41388-023-02607-8
Publication status	Published - 10 Mar 2023

Access to Document

https://doi.org/10.1038/s41388-023-02607-8

Cite this

Song, D., Cismas, S., Crudden, C., Trocme, E., Worrall, C., Suleymanova, N., Lin, T., Zheng, H., Seregard, S., Girnita, A., & Girnita, L. (2023). Correction: IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma (Oncogene, (2022), 41, 4, (600-611), 10.1038/s41388-021-02111-x). Oncogene, 42(11), 858. https://doi.org/10.1038/s41388-023-02607-8

@article{e807e1e1fa4743d195d8500ff87ca6d8,

title = "Correction: IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma (Oncogene, (2022), 41, 4, (600-611), 10.1038/s41388-021-02111-x)",

abstract = "Following the publication of this article, the authors noted errors in the assembly of Fig. 2b. A corrected version is provided in which the western blot panel for the cell line CM2 has been replaced with images from an alternative repeat for the pIGF1R/IGF1R and pAkt/Akt. In addition, the CM1 panel is updated with longer exposure images for pIGF1R/IGF1R and pAkt to better demonstrate the absence of IGF1R and IGF1-induced signaling activation in this cell line. The description of the results and the figure legend remain unchanged, and the authors confirm that conclusions of this article are not affected by this correction. The authors apologize for any inconvenience this may have caused for readers.",

author = "Dawei Song and Sonia Cismas and Caitrin Crudden and Eric Trocme and Claire Worrall and Naida Suleymanova and Tingting Lin and Huiyuan Zheng and Stefan Seregard and Ada Girnita and Leonard Girnita",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s), under exclusive licence to Springer Nature Limited.",

year = "2023",

month = mar,

day = "10",

doi = "https://doi.org/10.1038/s41388-023-02607-8",

language = "English",

volume = "42",

pages = "858",

journal = "Oncogene",

issn = "0950-9232",

publisher = "Nature Publishing Group",

number = "11",

}

Song, D, Cismas, S, Crudden, C, Trocme, E, Worrall, C, Suleymanova, N, Lin, T, Zheng, H, Seregard, S, Girnita, A & Girnita, L 2023, 'Correction: IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma (Oncogene, (2022), 41, 4, (600-611), 10.1038/s41388-021-02111-x)', Oncogene, vol. 42, no. 11, pp. 858. https://doi.org/10.1038/s41388-023-02607-8

TY - JOUR

T1 - Correction

T2 - IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma (Oncogene, (2022), 41, 4, (600-611), 10.1038/s41388-021-02111-x)

AU - Song, Dawei

AU - Cismas, Sonia

AU - Crudden, Caitrin

AU - Trocme, Eric

AU - Worrall, Claire

AU - Suleymanova, Naida

AU - Lin, Tingting

AU - Zheng, Huiyuan

AU - Seregard, Stefan

AU - Girnita, Ada

AU - Girnita, Leonard

PY - 2023/3/10

Y1 - 2023/3/10

N2 - Following the publication of this article, the authors noted errors in the assembly of Fig. 2b. A corrected version is provided in which the western blot panel for the cell line CM2 has been replaced with images from an alternative repeat for the pIGF1R/IGF1R and pAkt/Akt. In addition, the CM1 panel is updated with longer exposure images for pIGF1R/IGF1R and pAkt to better demonstrate the absence of IGF1R and IGF1-induced signaling activation in this cell line. The description of the results and the figure legend remain unchanged, and the authors confirm that conclusions of this article are not affected by this correction. The authors apologize for any inconvenience this may have caused for readers.

AB - Following the publication of this article, the authors noted errors in the assembly of Fig. 2b. A corrected version is provided in which the western blot panel for the cell line CM2 has been replaced with images from an alternative repeat for the pIGF1R/IGF1R and pAkt/Akt. In addition, the CM1 panel is updated with longer exposure images for pIGF1R/IGF1R and pAkt to better demonstrate the absence of IGF1R and IGF1-induced signaling activation in this cell line. The description of the results and the figure legend remain unchanged, and the authors confirm that conclusions of this article are not affected by this correction. The authors apologize for any inconvenience this may have caused for readers.

UR - http://www.scopus.com/inward/record.url?scp=85147662579&partnerID=8YFLogxK

U2 - https://doi.org/10.1038/s41388-023-02607-8

DO - https://doi.org/10.1038/s41388-023-02607-8

M3 - Comment/Letter to the editor

C2 - 36759575

SN - 0950-9232

VL - 42

SP - 858

JO - Oncogene

JF - Oncogene

IS - 11

ER -

Correction: IGF-1R is a molecular determinant for response to p53 reactivation therapy in conjunctival melanoma (Oncogene, (2022), 41, 4, (600-611), 10.1038/s41388-021-02111-x)

Abstract

Access to Document

Other files and links

Cite this